Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia.
Division of Endocrinology, Diabetes, Metabolism and Nutrition Department of Internal Medicine Mayo Clinic, Rochester, MN, USA.
J G
JG
Sfeir
Division of Endocrinology, Diabetes, Metabolism and Nutrition Department of Internal Medicine Mayo Clinic, Rochester, MN, USA.
M T
MT
Drake
Division of Biomedical Statistics and Informatics Mayo Clinic, Rochester, MN, USA.
B R
BR
LaPlant
Division of Biomedical Statistics and Informatics Mayo Clinic, Rochester, MN, USA.
M J
MJ
Maurer
Holden Comprehensive Cancer Center University of Iowa, Iowa City, IA, USA.
B K
BK
Link
Mayo Clinic Health Science Research, Rochester, MN, USA.
T J
TJ
Berndt
Mayo Clinic Cancer Center Mayo Clinic, Rochester, MN, USA.
T D
TD
Shanafelt
Mayo Clinic Health Science Research, Rochester, MN, USA.
J R
JR
Cerhan
Mayo Clinic Cancer Center Mayo Clinic, Rochester, MN, USA.
T M
TM
Habermann
Department of Laboratory Medicine and Pathology Mayo Clinic, Rochester, MN, USA.
A L
AL
Feldman
Mayo Clinic Cancer Center Mayo Clinic, Rochester, MN, USA.
T
T
Witzig
D002762:Cholecalciferol / Q000097:blood / Q000172:deficiency / Q000627:therapeutic use*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000150:complications*; D008223:Lymphoma / Q000097:blood / Q000150:complications*; D014808:Vitamin D Deficiency / Q000150:complications* / Q000188:drug therapy*
D002762:Cholecalciferol